Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its trading window for dealing in company securities will remain closed for designated persons and their immediate relatives starting Thursday, 1st January 2026. The closure will last until 48 hours after the end of the Board Meeting where unaudited financial results for the quarter ended 31st December 2025 (Q3 FY26) will be approved and declared. This is a standard compliance filing under SEBI's Insider Trading Regulations, 2015. The intimation was signed by Managing Director Fredun Nariman Medhora on 31st December 2025.
This is a routine regulatory filing with no direct impact on shareholders. It signals that the company's Q3 FY26 results announcement is imminent, which is the event investors should watch for potential stock price movement.